A detailed history of Corton Capital Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 3,344 shares of MRK stock, worth $328,915. This represents 0.19% of its overall portfolio holdings.

Number of Shares
3,344
Holding current value
$328,915
% of portfolio
0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $371,685 - $431,275
3,344 New
3,344 $379,000
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $1.48 Million - $1.61 Million
14,809 New
14,809 $1.61 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $202,511 - $259,646
2,316 New
2,316 $256,000
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $359,340 - $407,330
4,304 New
4,304 $392,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.